RNAi News GenomeWeb News Premium Content Existing subscribers login here. New to RNAi News? For a trial subscription click here.

Alnylam Publishes Data on Novel Delivery
Agent for siRNA-, miRNA-Targeting Drugs

[May 1, 2008]

By Doug Macron

As previously reported by RNAi News, Alnylam intends to use the delivery technology, known as lipidoids, in both its hypercholesterolemia and liver cancer drug programs.

Login | Subscribe